Detrol, also known by its generic name tolterodine, is a medication used to treat overactive bladder symptoms such as frequent or urgent urination and urinary incontinence. The active ingredient is tolterodine tartrate. Another name for Detrol is tolterodine.
The fiscal range for Detrol stands at £0.8 to £2.99 per pills. The crux of the pricing revolves around pack dimensions and ingredient quality (30 or 360 mg).
Detrol contains the active ingredient tolterodine tartrate. The medication is available in tablet and extended-release capsule forms. The exact dosage varies, typically 1 mg or 2 mg tablets and 2 mg or 4 mg extended-release capsules.
Tolterodine, the active component of Detrol, acts as a competitive muscarinic receptor antagonist. This action reduces bladder contractions, increases bladder capacity, and decreases the urgency and frequency of urination.
Detrol is primarily prescribed for the treatment of overactive bladder (OAB) symptoms. These symptoms include urinary incontinence, urgency, and frequency. It directly addresses these symptoms by targeting bladder muscle receptors.
Detrol is typically administered orally, with or without food. The extended-release capsule should be swallowed whole, not chewed or crushed. Correct dosing schedules must be adhered to for optimal effectiveness and minimal side effects.
Detrol is absorbed in the gastrointestinal tract, with peak plasma concentrations occurring 1-2 hours post administration for tablets and 4-6 hours for extended-release capsules. It is metabolized in the liver by the CYP2D6 pathway.
Concomitant use with potent CYP3A4 inhibitors like ketoconazole and erythromycin may increase tolterodine levels. Care should also be taken with anticholinergic drugs, which can enhance side effects. Co-administration with drugs affecting QT interval should be approached with caution.
For patients with significant renal impairment, dosage adjustments are advised. The dosage should not exceed one 2 mg tablet twice daily or one 2 mg capsule once daily to prevent potential toxicity.
Patients with mild to moderate hepatic impairment should be monitored closely. In severe hepatic impairment cases, Detrol use is generally not recommended. Reduced clearance may necessitate lower dosing.
The elderly may have slower metabolic rates, leading to increased plasma concentrations of Detrol. Dose adjustments should be considered based on clinical response and tolerability.
Common adverse effects include dry mouth, headache, constipation, and dry eyes. These effects are typically mild to moderate in severity. Patients should report persistent or severe symptoms to their healthcare provider.
Rare but serious side effects include angioedema, tachycardia, hallucinations, and severe allergic reactions. Immediate medical attention is necessary if these symptoms occur. Electrocardiographic monitoring may be advisable with symptoms suggestive of QT interval prolongation.
There is limited data regarding the use of Detrol during pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown no teratogenic effects at doses similar to therapeutic human doses.
Detrol can cause dizziness and blurred vision, impacting the ability to operate machinery or drive. Patients are advised to assess their individual response to the medication before engaging in such activities.
Detrol’s presence in human milk is unknown; nursing mothers should decide whether to discontinue nursing or the drug based on the importance of the drug to the mother. The potential for serious adverse reactions in breastfed infants should guide this decision.
Regular medical appointments must be maintained to monitor the effectiveness and safety of Detrol uso. Laboratory tests, including liver function tests and renal function panels, may be necessary given patient condition and comorbidities.
If a dose is missed, it should be taken as soon as remembered. However, if it is close to the next scheduled dose, the missed dose should be skipped to avoid double dosing. Maintaining a consistent dosing schedule is essential for therapeutic efficacy.
In case of overdose, immediate medical attention is required. Symptoms may include severe anticholinergic effects such as pronounced dry mouth, blurred vision, and central nervous system effects. Activated charcoal may be considered to limit drug absorption.
Store Detrol at room temperature, between 20-25°C (68-77°F). Protect from moisture and light. Proper storage ensures drug potency and effectiveness over the period of intended use.